Literature DB >> 23677745

Crack cocaine use due to dopamine agonist therapy in Parkinson disease.

Joseph H Friedman1, Victoria Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677745      PMCID: PMC3721099          DOI: 10.1212/WNL.0b013e318296e9d5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.

Authors:  T V Khroyan; R L Barrett-Larimore; J K Rowlett; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

Review 2.  Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.

Authors:  Atbin Djamshidian; Bruno B Averbeck; Andrew J Lees; Sean S O'Sullivan
Journal:  J Neurol Sci       Date:  2011-08-11       Impact factor: 3.181

3.  Inhaled cocaine used to relieve "off" periods in patients with Parkinson disease and unpredictable motor fluctuations: a report of 2 cases.

Authors:  Alessandro Di Rocco; Sabina Nasser; Peter Werner
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

4.  Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Authors:  Gregory T Collins; Yen Nhu-Thi Truong; Beth Levant; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2011-01-05       Impact factor: 4.530

Review 5.  Dopaminergic dysregulation syndrome in Parkinson's disease.

Authors:  Regina Katzenschlager
Journal:  J Neurol Sci       Date:  2011-08-25       Impact factor: 3.181

Review 6.  Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

Authors:  Roberto Cilia; Thilo van Eimeren
Journal:  Brain Struct Funct       Date:  2011-05-04       Impact factor: 3.270

  6 in total
  7 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

2.  Liking, wanting, and the incentive-sensitization theory of addiction.

Authors:  Kent C Berridge; Terry E Robinson
Journal:  Am Psychol       Date:  2016-11

Review 3.  A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction.

Authors:  Antoine Bechara; Kent C Berridge; Warren K Bickel; Jose A Morón; Sidney B Williams; Jeffrey S Stein
Journal:  Psychol Sci Public Interest       Date:  2019-10

Review 4.  Pleasure systems in the brain.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Neuron       Date:  2015-05-06       Impact factor: 17.173

5.  Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model.

Authors:  Davide Cenci; Manuel Glauco Carbone; Camilla Callegari; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

Review 6.  Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease.

Authors:  Atbin Djamshidian; Werner Poewe; Birgit Högl
Journal:  Parkinsons Dis       Date:  2015-11-18

Review 7.  Evolving Concepts of Emotion and Motivation.

Authors:  Kent C Berridge
Journal:  Front Psychol       Date:  2018-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.